You are Here : Moneycontrol Markets IPO Glenmark Life Sciences
Description They are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, They have established strong relationships with leading global generic pharmaceutical companies that have helped us expand Their product offerings and geographic reach. They work with 16 .... More »
Address Plot No. 170-172 Chandramouli, Industrial Est.Mohol Bazarpeth, Solapur Maharashtra , India. Pincode : 413213
As on Date | QIB | NII | RII | EMP | Total |
---|---|---|---|---|---|
28-Jul-2021 00:00 | 0.98 | 0.87 | 4.61 | 2.78 | |
27-Jul-2021 00:00 | 0.00 | 0.26 | 2.85 | 1.49 |
Issue price / Floor Price (Rs) | 695.00-720.00 |
Application per share (Rs) | 720.00 |
Minimum investment amount (Rs) | 14,400.00 |
Minimum bid (no of shares) | 20 |
Maximum Shares for Retail | N.A. |
Issue opens | 27-Jul-21 |
Issue closes | 29-Jul-21 |
Listing on | BSE NSE |
Issue size (Rs cr) | 1497.85 - 1513. |
Mkt cap at issue price (Rs cr) | N.A. |
Lead Manager |
---|
Kotak Mahindra Capital Company Limited | gls.ipo@kotak.com |
BofA Securities India Limited | dg.glenmark_ipo@bofa.com |
Registrar | KFin Technologies Private Limited |
glenmark.ipo@kfintech.com |
Shares on Offer | Lakhs |
---|---|
Total shares offered | N.A. |
Of above, offered to public | N.A. |
Post-issue shares | N.A. |
Post-issue promoters' holding(%) | N.A. |
Financials | Crore |
---|---|
No of months | N.A. |
Turnover | N.A. |
Net profit / (loss) | N.A. |
Borrowings | N.A. |